169 related articles for article (PubMed ID: 23348020)
1. Compensated heart failure does not always alleviate overestimation of liver stiffness by transient elastography.
Park Y; Kim SU; Koh MJ; Lee S
Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):385-7. PubMed ID: 23348020
[No Abstract] [Full Text] [Related]
2. Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate.
Lertnawapan R; Chonprasertsuk S; Siramolpiwat S
Int J Rheum Dis; 2019 Feb; 22(2):214-221. PubMed ID: 30565876
[TBL] [Abstract][Full Text] [Related]
3. Liver stiffness correlates with methotrexate cumulative dose in patients with rheumatoid arthritis.
Arena U; Stasi C; Mannoni A; Benucci M; Maddali-Bongi S; Cammelli D; Assarat A; Marra F; Pinzani M
Dig Liver Dis; 2012 Feb; 44(2):149-53. PubMed ID: 21930442
[TBL] [Abstract][Full Text] [Related]
4. Assessment of liver fibrosis by transient elastography in rheumatoid arthritis patients treated with methotrexate.
Park SH; Choe JY; Kim SK
Joint Bone Spine; 2010 Dec; 77(6):588-92. PubMed ID: 20471892
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate therapy is not associated with increased liver stiffness and significant liver fibrosis in rheumatoid arthritis patients: A cross-sectional controlled study with real-time two-dimensional shear wave elastography.
Erre GL; Cadoni ML; Meloni P; Castagna F; Mangoni AA; Piga M; Passiu G; Carru C; Zinellu A; Vidili G
Eur J Intern Med; 2019 Nov; 69():57-63. PubMed ID: 31474422
[TBL] [Abstract][Full Text] [Related]
6. Transient Elastography May Improve Detection of Liver Fibrosis in Psoriasis Patients Treated with Methotrexate.
Talme T; Nikamo P; Rosenberg P; Ståhle M
Acta Derm Venereol; 2017 Aug; 97(8):952-954. PubMed ID: 28422266
[No Abstract] [Full Text] [Related]
7. MTHFR polymorphisms, C677T and A1298C, are not a genetic risk factor for liver stiffness index in methotrexate-treated rheumatoid arthritis patients.
Choe JY; Park SH; Kim SK
Clin Exp Rheumatol; 2011; 29(1):144-5. PubMed ID: 21269580
[No Abstract] [Full Text] [Related]
8. Methotrexate does not increase the risk of liver fibrosis in patients with rheumatoid arthritis: assessment by ultrasound elastography (ARFI-MetRA study).
Feuchtenberger M; Kraus L; Nigg A; Schulze-Koops H; Schäfer A
Rheumatol Int; 2021 Jun; 41(6):1079-1087. PubMed ID: 33608744
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate hepatotoxicity: what is the evidence?
Ahern MJ; Smith MD; Roberts-Thomson PJ
Inflamm Res; 1998 Apr; 47(4):148-51. PubMed ID: 9628257
[No Abstract] [Full Text] [Related]
10. Comparison of transient elastography, serum markers and clinical signs for the diagnosis of compensated cirrhosis.
Malik R; Lai M; Sadiq A; Farnan R; Mehta S; Nasser I; Challies T; Schuppan D; Afdhal N
J Gastroenterol Hepatol; 2010 Sep; 25(9):1562-8. PubMed ID: 20796156
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of liver fibrosis by transient elastography in methotrexate treated patients.
Barbero-Villares A; Mendoza J; Trapero-Marugan M; Gonzalez-Alvaro I; Daudén E; Gisbert JP; Moreno-Otero R
Med Clin (Barc); 2011 Nov; 137(14):637-9. PubMed ID: 21719043
[TBL] [Abstract][Full Text] [Related]
12. My doctor recommended I take methotrexate to relieve the pain of the rheumatoid arthritis I have in my shoulder. But I've heard that methotrexate can cause liver problems. How will I know if I'm developing liver problems?
Duke Med Health News; 2009 Nov; 15(11):8. PubMed ID: 20050209
[No Abstract] [Full Text] [Related]
13. Liver toxicity does not have to follow methotrexate therapy of patients with rheumatoid arthritis.
Kremer JM
Am J Gastroenterol; 1997 Feb; 92(2):194-6. PubMed ID: 9040190
[No Abstract] [Full Text] [Related]
14. Comparison of methods for identifying early methotrexate-induced hepatotoxicity in patients with rheumatoid arthritis.
Arias JM; Morton KA; Albro JE; Patch GG; Valdivia S; Greenberg HE; Christian PE; Datz FL
J Nucl Med; 1993 Nov; 34(11):1905-9. PubMed ID: 8229232
[TBL] [Abstract][Full Text] [Related]
15. Performance and utility of transient elastography and noninvasive markers of liver fibrosis in primary biliary cirrhosis.
Floreani A; Cazzagon N; Martines D; Cavalletto L; Baldo V; Chemello L
Dig Liver Dis; 2011 Nov; 43(11):887-92. PubMed ID: 21783442
[TBL] [Abstract][Full Text] [Related]
16. Transient Elastography for Monitoring for Hepatotoxicity in Rheumatoid Arthritis Patients on Long-term Methotrexate.
Wade SD; Yoshida EM; Carruthers MN; Weinblatt ME
J Clin Rheumatol; 2021 Jun; 27(4):e131-e134. PubMed ID: 30106792
[No Abstract] [Full Text] [Related]
17. Magnetic resonance elastography and transient elastography as non-invasive analyses for liver fibrosis: can they obviate the need for liver biopsy in psoriasis patients treated with methotrexate?
Kaffenberger BH; Kaffenberger JA; Wong H; Jarjour W; Levin D; Bechtel MA
Int J Dermatol; 2015 Jul; 54(7):752-6. PubMed ID: 26108262
[TBL] [Abstract][Full Text] [Related]
18. Spleen stiffness measurement using Fibroscan for the noninvasive assessment of esophageal varices in liver cirrhosis patients.
Stefanescu H; Grigorescu M; Lupsor M; Procopet B; Maniu A; Badea R
J Gastroenterol Hepatol; 2011 Jan; 26(1):164-70. PubMed ID: 21175810
[TBL] [Abstract][Full Text] [Related]
19. Liver biopsy in the era of elastography.
Sporea I
Med Ultrason; 2011 Sep; 13(3):185-6. PubMed ID: 21894287
[No Abstract] [Full Text] [Related]
20. Methotrexate-induced liver abnormalities in rheumatoid arthritis.
Bridges SL; Alarcón GS; Koopman WJ
J Rheumatol; 1989 Sep; 16(9):1180-3. PubMed ID: 2681761
[No Abstract] [Full Text] [Related]
[Next] [New Search]
